Moderna Stock

Moderna Forward P/E

The Forward P/E Ratio of Moderna (MRNA) as of Jul 30, 2026 is -5.85. In the previous year, Forward P/E Ratio was -4.63 — a change of 26.19% (lower).

Forward P/E

-5.85

YoY

26.19%

Last updated:

Forward P/E Ratio of Moderna is 2026 -5.85 . Forward P/E Ratio of Moderna was 2025 -4.63 . It decreases by 26.19% lower compared to the previous year.
Access this data via the Eulerpool API

Moderna Stock analysis

What does Moderna do? Moderna Inc is a biotechnology company from the USA that specializes in the development of therapies and vaccines based on mRNA technology. The company was founded in 2010 by a group of researchers led by Noubar Afeyan and is headquartered in Cambridge, Massachusetts. Moderna is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Moderna stock

Forward P/E Ratio of Moderna is -5.85 in 2026.

Access this data via the Eulerpool API

Valuation — Moderna

All Key Metrics — Moderna